Abbott and Omada Health Partner to Help People With Type 2 Diabetes
On October 14, 2019, Abbott and Omada Health announced a partnership to integrate Abbott’s FreeStyle Libre continuous glucose monitoring system (CGM) with Omada Health’s digital program for people with Type 2 diabetes. With 90 to 95 percent of all diabetes cases being Type 2 diabetes, Abbott and Omada aim to help individuals with the disease find a simpler way to manage it as well as their overall health.
“The mission of Omada Health has always been to empower meaningful, sustainable behavior change for those individuals living with Type 2 diabetes and other chronic conditions,” said Omada co-founder and chief executive officer Sean Duffy. “Partnering with Abbott to give individuals access to FreeStyle Libre as part of the Omada program will deliver a unique combination of personalized human coaching and technology-enabled care to support those goals.”
This integration between Abbott and Omada Health stems from the companies’ algorithms and analytics to help those who use the FreeStyle Libre to receive real-time glucose data and actionable information, including personalized recommendations from their assigned certified diabetes educator (CDE) through online chats in Omada’s app. Eligible people with Type 2 diabetes will also receive a tailored, personalized experience that includes an online consultation by a physician, a FreeStyle Libre prescription, and a welcome kit that includes the CGM and a wireless scale. This program will be available to employers and health plans.
“I’ve worked as a registered dietitian and certified diabetes educator for more than 10 years,” said Danene ‘DJ’ Moberly, registered dietitian, and CDE coach, Omada Health. “The biggest barriers to success for my patients have always been immediate access to a diabetes educator when they need it most and a lack of accurate glucose and nutrition data so that we can personalize treatment. It’s exciting that this partnership addresses both needs and will give people living with Type 2 diabetes access to an unprecedented suite of tools and personalized support to better manage their condition.”
The Freestyle Libre is worn on the back of the upper arm and using a smartphone or the device’s reader, users can get a one-second scan with real-time glucose readings without having to use fingersticks. Information on the glucose readings also shows arrows to tell individuals the trend of their blood glucose — if it’s rising, stabilizing, or lowering. People can also view their 8-hour glucose history on the FreeStyle LibreLink app and share their readings with up to 20 people using the LibreLinkUp app. People can also use the LibreView, a cloud-based diabetes management system, that gives people with diabetes and their healthcare team clear, easy-to-understand reports.
“We’ve seen how FreeStyle Libre transforms lives through its proven track record in improving health outcomes, and our goal is to find new ways for even more people with diabetes to benefit from this technology,” said Jared Watkin, senior vice president, Diabetes Care, Abbott. “Through this collaboration, we’re creating a personalized care experience that combines Abbott’s leading CGM technology with Omada Health’s professional coaching and digital platform – giving people with Type 2 diabetes actionable information that leads to better health.”
To learn more about continuous glucose monitoring, click here.
Abbott is a Founding Partner of Beyond Type 2. Beyond Type 2 maintains full editorial control of news involving partners.